白细胞介素-6 与肺内分流。
Interleukin-6 and intrapulmonary shunt.
机构信息
Dept of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
出版信息
Eur Respir J. 2021 Aug 12;58(2). doi: 10.1183/13993003.01292-2021. Print 2021 Aug.
Abstract
摘要
[网页链接]
相似文献
1
Interleukin-6 and intrapulmonary shunt.白细胞介素-6 与肺内分流。
Eur Respir J. 2021 Aug 12;58(2). doi: 10.1183/13993003.01292-2021. Print 2021 Aug.
2
Intrapulmonary shunt is a potentially unrecognized cause of ischemic stroke and transient ischemic attack.肺内分流是缺血性卒中和短暂性脑缺血发作潜在的未被识别的原因。
J Am Soc Echocardiogr. 2013 Jul;26(7):683-90. doi: 10.1016/j.echo.2013.04.004. Epub 2013 May 11.
3
Can Dexmedetomidine Improve Arterial Oxygenation and Intrapulmonary Shunt during One-lung Ventilation in Adults Undergoing Thoracic Surgery? A Meta-analysis of Randomized, Placebo-controlled Trials.右美托咪定能否改善胸外科手术成年患者单肺通气期间的动脉氧合及肺内分流？一项随机、安慰剂对照试验的荟萃分析。
Chin Med J (Engl). 2017 Jul 20;130(14):1707-1714. doi: 10.4103/0366-6999.209891.
4
Monocyte human leukocyte antigen-DR expression correlates with intrapulmonary shunting after major trauma.单核细胞人类白细胞抗原-DR表达与严重创伤后肺内分流相关。
Am J Surg. 1999 Jun;177(6):454-9. doi: 10.1016/s0002-9610(99)00099-9.
5
[Hepatopulmonary syndrome in liver cirrhosis].[肝硬化中的肝肺综合征]
Srp Arh Celok Lek. 2000 Jul-Aug;128(7-8):271-5.
6
Relation between migraine and size of echocardiographic intrapulmonary right-to-left shunt.超声心动图肺内右向左分流大小与偏头痛的关系。
Am J Cardiol. 2011 May 1;107(9):1399-404. doi: 10.1016/j.amjcard.2010.12.052. Epub 2011 Mar 2.
7
Lung destruction secondary to intrapulmonary migration of a ventriculoperitoneal shunt catheter: report of an unusual case and literature review.脑室腹腔分流管肺内迁移继发的肺破坏：1例罕见病例报告及文献复习
Childs Nerv Syst. 2021 Mar;37(3):989-993. doi: 10.1007/s00381-020-04716-1. Epub 2020 Jun 9.
8
Effect of initial gas bubble composition on detection of inducible intrapulmonary arteriovenous shunt during exercise in normoxia, hypoxia, or hyperoxia.在常氧、低氧或高氧条件下运动时，初始气泡气体组成对可诱导性肺内动静脉分流的检测影响。
J Appl Physiol (1985). 2011 Jan;110(1):35-45. doi: 10.1152/japplphysiol.00145.2010. Epub 2010 Sep 16.
9
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 concentrations in cerebrospinal fluid predict ventriculoperitoneal shunt infection.脑脊液中肿瘤坏死因子-α、白细胞介素-1β和白细胞介素-6的浓度可预测脑室腹腔分流感染。
Crit Care Med. 1997 Oct;25(10):1713-6. doi: 10.1097/00003246-199710000-00022.
10
Intravascular infusion of acid promotes intrapulmonary inducible nitric oxide synthase activity and impairs blood oxygenation in rats.血管内输注酸可促进大鼠肺内诱导型一氧化氮合酶活性并损害血液氧合。
Crit Care Med. 2003 May;31(5):1454-60. doi: 10.1097/01.CCM.0000065678.24064.58.
引用本文的文献
1
Intrapulmonary shunting is a key contributor to hypoxia in COVID-19: An update on the pathophysiology.肺内分流是导致 COVID-19 患者缺氧的一个关键因素：对病理生理学的最新认识。
PLoS One. 2022 Oct 20;17(10):e0273402. doi: 10.1371/journal.pone.0273402. eCollection 2022.
2
Diffuse large B-cell lymphoma presenting as reversible intrapulmonary arteriovenous shunts with hypoxia, fever and progressive jaundice: a case report and literature review.弥漫性大 B 细胞淋巴瘤表现为可逆性肺内动静脉分流伴低氧血症、发热和进行性黄疸：病例报告及文献复习。
BMC Pulm Med. 2022 Mar 15;22(1):89. doi: 10.1186/s12890-022-01881-8.
本文引用的文献
1
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.托珠单抗治疗 COVID-19 住院患者的疗效（RECOVERY）：一项随机、对照、开放标签、平台试验。
Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0.
2
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial.托珠单抗治疗中度或重度新型冠状病毒肺炎患者：一项随机、对照、开放标签、多中心试验。
Front Med. 2021 Jun;15(3):486-494. doi: 10.1007/s11684-020-0824-3. Epub 2021 Mar 9.
3
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
4
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.白细胞介素-6、降钙素原和中性粒细胞与淋巴细胞比值：潜在的免疫炎症参数，可用于识别 COVID-19 的严重和致命形式。
Cytokine. 2021 May;141:155428. doi: 10.1016/j.cyto.2021.155428. Epub 2021 Jan 15.
5
Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications.新型冠状病毒肺炎所致急性肺损伤的功能病理生理学及临床意义
J Appl Physiol (1985). 2021 Mar 1;130(3):877-891. doi: 10.1152/japplphysiol.00742.2020. Epub 2021 Jan 14.
6
Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19.床边脉搏血氧饱和度测定的肺内分流预测严重 COVID-19 患者的预后更差。
Eur Respir J. 2021 Apr 22;57(4). doi: 10.1183/13993003.03841-2020. Print 2021 Apr.
7
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis.托珠单抗治疗 COVID-19 患者的疗效和安全性：一项实时系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Feb;27(2):215-227. doi: 10.1016/j.cmi.2020.10.036. Epub 2020 Nov 5.
8
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
9
Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury.白细胞介素-6具有肺部抗炎特性，并在双打击小鼠急性肺损伤中发挥保护性血流动力学效应。
Respir Res. 2017 Apr 19;18(1):64. doi: 10.1186/s12931-017-0553-6.
10
Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunction.酸性鞘磷脂酶和白细胞介素 6 作为内毒素诱导的肺血管功能障碍的介质。
Thorax. 2017 May;72(5):460-471. doi: 10.1136/thoraxjnl-2015-208067. Epub 2016 Jul 27.
Zotero 插件